… protect the
tumor microenvironment from immunologic attack and contribute to
tumor growth … is being developed to address
prostate cancer. Advaxis entered into a clinical … with previously treated metastatic, castration-resistant
prostate cancer.
Advaxis is also developing Lm-LLO …
No comments:
Post a Comment